Citadel Advisors - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 39 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$197,000
-19.9%
160,768
+35.5%
0.00%
Q1 2022$246,000
-17.4%
118,685
-41.8%
0.00%
Q4 2021$298,000
-53.1%
203,797
-15.0%
0.00%
Q3 2021$635,000
-49.8%
239,699
-25.0%
0.00%
Q2 2021$1,266,000
+3.4%
319,788
+24.6%
0.00%
Q1 2021$1,224,000
+51.1%
256,631
+123.9%
0.00%
Q4 2020$810,000
-66.2%
114,600
-49.7%
0.00%
Q3 2020$2,399,000
+30.6%
227,831
+9.6%
0.00%
-100.0%
Q2 2020$1,837,000
+709.3%
207,800
+234.9%
0.00%
Q1 2020$227,000
+467.5%
62,044
+485.3%
0.00%
Q3 2019$40,00010,6000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 732,135$1,940,0000.83%
Green Alpha Advisors, LLC 61,759$164,0000.11%
Values First Advisors, Inc. 49,179$130,0000.08%
GSA CAPITAL PARTNERS LLP 257,684$683,0000.07%
SHELTON CAPITAL MANAGEMENT 240,000$636,0000.02%
Walleye Capital LLC 154,997$411,0000.01%
PDT Partners, LLC 59,400$157,0000.01%
Archford Capital Strategies, LLC 13,091$35,0000.01%
Susquehanna International Group Ltd. 13,164$35,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$444,0000.01%
View complete list of PLURISTEM THERAPEUTICS INC shareholders